173 related articles for article (PubMed ID: 3511404)
1. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
[TBL] [Abstract][Full Text] [Related]
2. Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters.
Anderson TJ; Donaldson IM; Sheat JM; George PM
Aust N Z J Med; 1990 Dec; 20(6):794-7. PubMed ID: 2291728
[TBL] [Abstract][Full Text] [Related]
3. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.
La Mantia L; Eoli M; Milanese C; Salmaggi A; Dufour A; Torri V
Eur Neurol; 1994; 34(4):199-203. PubMed ID: 7915989
[TBL] [Abstract][Full Text] [Related]
4. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
Milligan NM; Newcombe R; Compston DA
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):511-6. PubMed ID: 3295122
[TBL] [Abstract][Full Text] [Related]
5. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
[TBL] [Abstract][Full Text] [Related]
6. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
[No Abstract] [Full Text] [Related]
7. Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.
Baumhefner RW; Tourtellotte WW; Syndulko K; Staugaitis A; Shapshak P
Ital J Neurol Sci; 1989 Feb; 10(1):19-32. PubMed ID: 2925343
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic trials of multiple sclerosis and intrathecal IgG production.
Wender M; Tokarz E; Michalowska G; Wajgt A
Ital J Neurol Sci; 1986 Apr; 7(2):205-8. PubMed ID: 3013800
[TBL] [Abstract][Full Text] [Related]
9. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.
Compston DA; Milligan NM; Hughes PJ; Gibbs J; McBroom V; Morgan BP; Campbell AK
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):517-22. PubMed ID: 2953865
[TBL] [Abstract][Full Text] [Related]
10. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
Filippini G; Brusaferri F; Sibley WA; Citterio A; Ciucci G; Midgard R; Candelise L
Cochrane Database Syst Rev; 2000; (4):CD001331. PubMed ID: 11034713
[TBL] [Abstract][Full Text] [Related]
12. Intravenous methylprednisolone for multiple sclerosis in relapse.
Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis.
Cazzato G; Mesiano T; Antonello R; Monti F; Carraro N; Torre P; Bosco A; Cargnelutti D
Eur Neurol; 1995; 35(4):193-8. PubMed ID: 7671978
[TBL] [Abstract][Full Text] [Related]
14. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
Alam SM; Kyriakides T; Lawden M; Newman PK
J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1219-20. PubMed ID: 8229035
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Syndulko K; Holevoet-Howson MI; Lerner CD; Frane MV; Pettler-Jennings P
Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
[TBL] [Abstract][Full Text] [Related]
17. [Prospective evaluation of the effectiveness of high doses of methylprednisolone in multiple sclerosis].
Wajgt A; Szczechowski L; Marczewska E; Grechuta M; Strzyzewska L; Gadomska B; Szyrocka-Szwed K
Neurol Neurochir Pol; 1988; 22(3):188-94. PubMed ID: 3065667
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis de novo CNS IgG synthesis. Effect of CNS irradiation.
Tourtellotte WW; Potvin AR; Baumhefner RW; Potvin JH; Ma BI; Syndulko K; Petrovich Z
Arch Neurol; 1980 Oct; 37(10):620-4. PubMed ID: 6252876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
